Resveratrol attenuates inflammation by regulating macrophage polarization via inhibition of toll-like receptor 4/MyD88 signaling pathway

被引:5
|
作者
Fan, Yue [1 ]
Huang, Si-Lin [2 ]
Li, Hong [3 ]
Cui, Yu-Lin [4 ]
Li, Dong-yan [5 ]
机构
[1] Southern Univ Sci & Technol Hosp, Shenzhen, Peoples R China
[2] Shenzhen Univ, Hlth Sci Ctr, Gastroenterol, South China Hosp, Shenzhen, Peoples R China
[3] Southern Med Univ, Shenzhen Hosp, Shenzhen, Peoples R China
[4] China Med Univ, Shenyang, Peoples R China
[5] Jinzhou Med Univ, Affiliated Hosp 1, Jinzhou, Peoples R China
关键词
Lipopolysaccharide; macrophages; polarization; resveratrol; toll-like receptor 4; MyD88; INJURY; LIPOPOLYSACCHARIDE; EXPRESSION;
D O I
10.4103/pm.pm_312_20
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Background: Resveratrol (RES) can induce macrophage polarization to achieve the immune response. Objectives: In this study, we aimed to determine whether RES attenuates inflammation by regulating macrophage polarization through inhibition of toll-like receptor 4 (TLR4)/MyD88 signaling. Materials and Methods: We measured the effects of different concentrations of RES on cellular activity of RAW264.7 and measured it using the methyl thiazolyl blue tetrazolium bromide method. The immunomodulatory effects of RES on lipopolysaccharide (LPS)-induced RAW264.7 cells were detected by measuring the levels of nitric oxide (NO), interleukin (IL)-6, and tumor necrosis factor (TNF)-alpha. The quantitative real-time polymerase chain reaction (RT-qPCR) was used to detect the markers of M1 and M2 polarization of macrophages. The changes in the expression of both mRNA and proteins related to the TLR4/ myeloid differentiation factor 88 (MyD88) receptor pathway detected by Western blot (WB) and RT-qPCR analyses. Results: According to our results, 2, 4, and 8 mu mol/L RES decreased the levels of NO, IL-6, and TNF-alpha in LPS-induced RAW264.7 cells, thereby reducing inflammation and increasing immunity. IL-1 and inducible NO synthase, which are the markers of M1-type macrophages, were increased by LPS, and arginase-1, CD206, which are the markers of M2-type macrophages, were decreased. However, in LPS-induced RAW264.7 cells incubated with RES, we observed the opposite results for both M1-and M2-type macrophage markers. Proteins and mRNA related to the TLR4 pathway were detected by WB and RT-qPCR analysis and TLR4, P65, MyD88, interleukin receptor-associated kinases 1, tumor necrosis factor receptor associated factor 6, activated kinase 1, and IKK beta were significantly increased by LPS. In contrast, when the cells were incubated with RES, the TLR4 pathway-related proteins and mRNA were significantly decreased and showed a volume-response relationship. Conclusion: RES can polarize M1-type macrophages to M2-type macrophages and regulate them through the TLR4/MyD88 receptor pathway. The polarization of macrophages can reduce the level of inflammation and regulate the immune system.
引用
收藏
页码:321 / 326
页数:6
相关论文
共 50 条
  • [31] Disruption of downstream MyD88 or TRIF Toll-like receptor signaling does not protect against cerebral ischemia
    Famakin, Bolanle M.
    Mou, Yongshan
    Ruetzler, Christ A.
    Bembry, Joliet
    Maric, Dragan
    Hallenbeck, John M.
    BRAIN RESEARCH, 2011, 1388 : 148 - 156
  • [32] Overexpression of the Toll-Like Receptor (TLR) Signaling Adaptor MYD88, but Lack of Genetic Mutation, in Myelodysplastic Syndromes
    Dimicoli, Sophie
    Wei, Yue
    Bueso-Ramos, Carlos
    Yang, Hui
    DiNardo, Courtney
    Jia, Yu
    Zheng, Hong
    Fang, Zhihong
    Martin Nguyen
    Pierce, Sherry
    Chen, Rui
    Wang, Hui
    Wu, Chenghua
    Garcia-Manero, Guillermo
    PLOS ONE, 2013, 8 (08):
  • [33] Cells Stimulated with More Than One Toll-Like Receptor-Ligand in the Presence of a MyD88 Inhibitor Augmented Interferon-beta via MyD88-Independent Signaling Pathway
    Saikh, Kamal U.
    Ranji, Cyra M.
    VIRAL IMMUNOLOGY, 2021, 34 (09) : 646 - 652
  • [34] MyD88 is essential for clearance of Leishmania major:: possible role for lipophosphoglycan and Toll-like receptor 2 signaling
    de Veer, MJ
    Curtis, JM
    Baldwin, TM
    DiDonato, JA
    Sexton, A
    McConville, MJ
    Handman, E
    Schofield, L
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2003, 33 (10) : 2822 - 2831
  • [35] MyD88 Death-Domain Oligomerization Determines Myddosome Architecture: Implications for Toll-like Receptor Signaling
    Moncrieffe, Martin C.
    Bollschweiler, Daniel
    Li, Bing
    Penczek, Pawel A.
    Hopkins, Lee
    Bryant, Clare E.
    Klenerman, David
    Gay, Nicholas J.
    STRUCTURE, 2020, 28 (03) : 281 - +
  • [36] SPOP negatively regulates Toll-like receptor-induced inflammation by disrupting MyD88 self-association
    Yun-Hong Hu
    Yang Wang
    Fei Wang
    Yan-Ming Dong
    Wan-Ling Jiang
    Ya-Ping Wang
    Xing Zhong
    Li-Xin Ma
    Cellular & Molecular Immunology, 2021, 18 : 1708 - 1717
  • [37] Role of MyD88 and Toll-Like Receptors 2 and 4 in the Sensing of Parachlamydia acanthamoebae
    Roger, Thierry
    Casson, Nicola
    Croxatto, Antony
    Entenza, Jose Manuel
    Pusztaszeri, Marc
    Akira, Shizuo
    Reymond, Marlies Knaup
    Le Roy, Didier
    Calandra, Thierry
    Greub, Gilbert
    INFECTION AND IMMUNITY, 2010, 78 (12) : 5195 - 5201
  • [38] SPOP negatively regulates Toll-like receptor-induced inflammation by disrupting MyD88 self-association
    Hu, Yun-Hong
    Wang, Yang
    Wang, Fei
    Dong, Yan-Ming
    Jiang, Wan-Ling
    Wang, Ya-Ping
    Zhong, Xing
    Ma, Li-Xin
    CELLULAR & MOLECULAR IMMUNOLOGY, 2021, 18 (07) : 1708 - 1717
  • [39] Inhibition of MyD88 attenuates angiotensin II-induced hypertensive kidney disease via regulating renal inflammation
    Lin, Ke
    Luo, Wu
    Yang, Na
    Su, Lan
    Zhou, Hao
    Hu, Xiang
    Wang, Yi
    Khan, Zia A.
    Huang, Weijian
    Wu, Gaojun
    Liang, Guang
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2022, 112
  • [40] The mitochondrial protein, Toag-1, interferes with MyD88 dependent Toll-like receptor signaling in dendritic cells
    Vogel, S.
    Schlickeiser, S.
    Panov, I.
    Schroeder, M.
    Lutz, M. B.
    Lehnardt, S.
    Vogt, K.
    Gruetz, G.
    Sawitzki, B.
    IMMUNOLOGY, 2012, 137 : 252 - 252